Fic Capital Boosted By $470,250 Its Facebook Cl A (FB) Holding; Cidara Therapeutics (CDTX) Shorts Lowered By 4.35%

December 1, 2017 - By Louis Casey

Fic Capital Inc increased Facebook Inc Cl A (FB) stake by 19.54% reported in 2017Q2 SEC filing. Fic Capital Inc acquired 3,135 shares as Facebook Inc Cl A (FB)’s stock rose 10.88%. The Fic Capital Inc holds 19,177 shares with $2.90M value, up from 16,042 last quarter. Facebook Inc Cl A now has $510.41 billion valuation. The stock decreased 0.86% or $1.53 during the last trading session, reaching $175.65. About 15.17 million shares traded. Facebook, Inc. (NASDAQ:FB) has risen 26.75% since December 1, 2016 and is uptrending. It has outperformed by 10.05% the S&P500.

Cidara Therapeutics Incorporated (NASDAQ:CDTX) had a decrease of 4.35% in short interest. CDTX’s SI was 386,600 shares in December as released by FINRA. Its down 4.35% from 404,200 shares previously. With 97,000 avg volume, 4 days are for Cidara Therapeutics Incorporated (NASDAQ:CDTX)’s short sellers to cover CDTX’s short positions. The SI to Cidara Therapeutics Incorporated’s float is 4.22%. The stock increased 0.63% or $0.05 during the last trading session, reaching $7.95. About 38,594 shares traded. Cidara Therapeutics, Inc. (NASDAQ:CDTX) has declined 38.96% since December 1, 2016 and is downtrending. It has underperformed by 55.66% the S&P500.

Among 6 analysts covering Cidara Therapeutics (NASDAQ:CDTX), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Cidara Therapeutics had 13 analyst reports since October 9, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cantor Fitzgerald given on Thursday, August 10. The company was downgraded on Friday, September 23 by WBB Securities. On Wednesday, November 8 the stock rating was maintained by Cantor Fitzgerald with “Buy”. H.C. Wainwright initiated the stock with “Buy” rating in Monday, December 19 report. The firm has “Hold” rating given on Friday, October 9 by WBB Securities. The firm has “Sell” rating given on Friday, July 28 by WBB Securities. WBB Securities upgraded the stock to “Hold” rating in Friday, August 11 report. Needham maintained Cidara Therapeutics, Inc. (NASDAQ:CDTX) on Tuesday, October 3 with “Buy” rating. Cantor Fitzgerald maintained the shares of CDTX in report on Friday, June 23 with “Buy” rating. Leerink Swann reinitiated the shares of CDTX in report on Wednesday, December 21 with “Outperform” rating.

Cidara Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of various diseases. The company has market cap of $160.89 million. The Company’s lead product candidate is CD101 IV, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of serious, invasive fungal infections. It currently has negative earnings. The firm also develops CD201, a novel bispecific antimicrobial immunotherapy for the treatment of multidrug-resistant gram-negative bacterial infections, including those caused by pathogens harboring the mcr-1 plasmid.

Since June 6, 2017, it had 0 insider purchases, and 8 insider sales for $76.02 million activity. On Thursday, June 8 Zuckerberg Mark sold $21.25 million worth of Facebook, Inc. (NASDAQ:FB) or 138,149 shares. Cox Christopher K also sold $2.45 million worth of Facebook, Inc. (NASDAQ:FB) shares. On Tuesday, June 6 Stretch Colin sold $115,308 worth of Facebook, Inc. (NASDAQ:FB) or 750 shares. Schroepfer Michael Todd sold $5.71M worth of stock. Another trade for 163,500 shares valued at $25.14 million was sold by Sandberg Sheryl.

Investors sentiment increased to 1.4 in Q2 2017. Its up 0.05, from 1.35 in 2017Q1. It improved, as 48 investors sold FB shares while 553 reduced holdings. 159 funds opened positions while 684 raised stakes. 1.62 billion shares or 0.41% less from 1.63 billion shares in 2017Q1 were reported. Garde Cap Inc reported 4,014 shares or 0.15% of all its holdings. Loring Wolcott Coolidge Fiduciary Limited Liability Partnership Ma reported 348,453 shares. 1,867 are held by Charter Tru. 59,491 were accumulated by Fulton Bank Na. Ws Management Lllp holds 2.76% of its portfolio in Facebook, Inc. (NASDAQ:FB) for 491,600 shares. Mirae Asset Ltd, Korea-based fund reported 503,844 shares. Markel Corporation holds 98,500 shares. Financial Advisory Gru holds 0.09% or 1,683 shares. Eagle Capital Mngmt Ltd Liability Co has 2.05% invested in Facebook, Inc. (NASDAQ:FB). Ami Asset reported 144,210 shares. Signaturefd Limited Liability Company invested in 9,164 shares. Hwg Ltd Partnership invested in 8,696 shares. Inverness Counsel Ltd Liability New York reported 226,067 shares stake. Columbus Circle stated it has 931,592 shares or 2.32% of all its holdings. 110,874 are held by Jag Capital Management Lc.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.